Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 4302470, 9 pages
http://dx.doi.org/10.1155/2016/4302470
Research Article

Systematic Identification and Bioinformatic Analysis of MicroRNAs in Response to Infections of Coxsackievirus A16 and Enterovirus 71

Key Laboratory of Enteric Pathogenic Microbiology, Ministry of Health, Jiangsu Provincial Center for Disease Prevention and Control, No. 172 Jiangsu Road, Nanjing 210009, China

Received 1 August 2016; Accepted 29 September 2016

Academic Editor: Cheng-Feng Qin

Copyright © 2016 Zheng Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Chea, Y. B. Cheng, K. Chokephaibulkit et al., “Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia,” Emerging Infectious Diseases, vol. 21, no. 1, Article ID e140992, 2015. View at Publisher · View at Google Scholar
  2. L.-Y. Chang, L.-M. Huang, S. S.-F. Gau et al., “Neurodevelopment and cognition in children after enterovirus 71 infection,” The New England Journal of Medicine, vol. 356, no. 12, pp. 1226–1234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. P. Alexander Jr., L. Baden, M. A. Pallansch, and L. J. Anderson, “Enterovirus 71 infections and neurologic disease—United States, 1977–1991,” Journal of Infectious Diseases, vol. 169, no. 4, pp. 905–908, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Kehle, B. Roth, C. Metzger, A. Pfitzner, and G. Enders, “Molecular characterization of an enterovirus 71 causing neurological disease in Germany,” Journal of NeuroVirology, vol. 9, no. 1, pp. 126–128, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. P. McMinn, I. Stratov, L. Nagarajan, and S. Davis, “Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia,” Clinical Infectious Diseases, vol. 32, no. 2, pp. 236–242, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. S. AbuBakar, H.-Y. Chee, N. Shafee, K. B. Chua, and S. K. Lam, “Molecular detection of enteroviruses from an outbreak of hand, foot and mouth disease in Malaysia in 1997,” Scandinavian Journal of Infectious Diseases, vol. 31, no. 4, pp. 331–335, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Ho, E.-R. Chen, K.-H. Hsu et al., “An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group,” The New England Journal of Medicine, vol. 341, no. 13, pp. 929–935, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Ahmad, “Hand, foot, and mouth disease outbreak reported in Singapore,” The Lancet, vol. 356, no. 9238, p. 1338, 2000. View at Google Scholar · View at Scopus
  9. S. AbuBakar, I.-C. Sam, J. Yusof et al., “Enterovirus 71 outbreak, Brunei,” Emerging Infectious Diseases, vol. 15, no. 1, pp. 79–82, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Xing, Q. Liao, C. Viboud et al., “Hand, foot, and mouth disease in China, 2008–2012: an epidemiological study,” The Lancet Infectious Diseases, vol. 14, no. 4, pp. 308–318, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. B. P. Lewis, C. B. Burge, and D. P. Bartel, “Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets,” Cell, vol. 120, no. 1, pp. 15–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. F. Olena, M. B. Rao, E. J. Thatcher, S.-Y. Wu, and J. G. Patton, “miR-216a regulates snx5, a novel notch signaling pathway component, during zebrafish retinal development,” Developmental Biology, vol. 400, no. 1, pp. 72–81, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. U. Gioia, V. Di Carlo, P. Caramanica et al., “Mir-23a and mir-125b regulate neural stem/progenitor cell proliferation by targeting Musashi1,” RNA Biology, vol. 11, no. 9, pp. 1105–1112, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Möhnle, S. V. Schütz, V. van der Heide et al., “MicroRNA-146a controls Th1-cell differentiation of human CD4+ T lymphocytes by targeting PRKCε,” European Journal of Immunology, vol. 45, no. 1, pp. 260–272, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. H.-Q. Zhu, Q. Li, L.-Y. Dong, Q. Zhou, H. Wang, and Y. Wang, “MicroRNA-29b promotes high-fat diet-stimulated endothelial permeability and apoptosis in apoE knock-out mice by down-regulating MT1 expression,” International Journal of Cardiology, vol. 176, no. 3, pp. 764–770, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Sandhu, J. Rein, M. D'Arcy, J. I. Herschkowitz, K. A. Hoadley, and M. A. Troester, “Overexpression of miR-146a in basal-like breast cancer cells confers enhanced tumorigenic potential in association with altered p53 status,” Carcinogenesis, vol. 35, no. 11, pp. 2567–2575, 2014. View at Publisher · View at Google Scholar
  18. G. J. Berry, L. R. Budgeon, T. K. Cooper, N. D. Christensen, and H. Waldner, “The type 1 diabetes resistance locus B10 Idd9.3 mediates impaired B-cell lymphopoiesis and implicates microRNA-34a in diabetes protection,” European Journal of Immunology, vol. 44, no. 6, pp. 1716–1727, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Fu, Y. Gao, Q. Zhou et al., “Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA,” Gene, vol. 536, no. 2, pp. 272–278, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. A. R. Marquitz, A. Mathur, P. E. Chugh, D. P. Dittmer, and N. Raab-Traub, “Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells,” Journal of Virology, vol. 88, no. 2, pp. 1389–1393, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. C. L. Jopling, M. Yi, A. M. Lancaster, S. M. Lemon, and P. Sarnow, “Molecular biology: modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA,” Science, vol. 309, no. 5740, pp. 1577–1581, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Zhu, Z. He, Y. Hu et al., “MicroRNA-30e suppresses dengue virus replication by promoting NF-κB–dependent IFN production,” PLoS Neglected Tropical Diseases, vol. 8, no. 8, Article ID e3088, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Kohno, M. Tsuge, E. Murakami et al., “Human microRNA hsa-miR-1231 suppresses hepatitis B virus replication by targeting core mRNA,” Journal of Viral Hepatitis, vol. 21, no. 9, pp. e89–e97, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. W.-F. Tang, R.-T. Huang, K.-Y. Chien et al., “Host microRNA miR-197 plays a negative regulatory role in the enterovirus 71 infectious cycle by targeting the RAN protein,” Journal of Virology, vol. 90, no. 3, pp. 1424–1438, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Y. Wang, K. Weng, Y. Huang, and C. Chen, “Elevated expression of circulating miR876-5p is a specific response to severe EV71 infections,” Scientific Reports, vol. 6, p. 24149, 2016. View at Publisher · View at Google Scholar
  26. Z. Yang and P. Tien, “MiR432 regulate the replication of coxsackievirus A16 in rhabdomyosarcoma cells,” Wei Sheng Wu Xue Bao, vol. 54, no. 6, pp. 679–687, 2014. View at Google Scholar · View at Scopus
  27. J.-F. Han, R.-Y. Cao, Y.-Q. Deng et al., “Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo,” Virology Journal, vol. 8, article 106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. B. M. Bolstad, R. A. Irizarry, M. Åstrand, and T. P. Speed, “A comparison of normalization methods for high density oligonucleotide array data based on variance and bias,” Bioinformatics, vol. 19, no. 2, pp. 185–193, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Song, X. An, L. Zhang et al., “Identification and profiling of microRNAs in goat endometrium during embryo implantation,” PLoS ONE, vol. 10, no. 4, Article ID e0122202, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. L.-J. Xu, T. Jiang, W. Zhao et al., “Parallel mRNA and microRNA profiling of HEV71-infected human neuroblastoma cells reveal the up-regulation of miR-1246 in association with DLG3 repression,” PLoS ONE, vol. 9, no. 4, Article ID e0095272, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. N. J. Thornburg, S. L. Hayward, and J. E. Crowe Jr., “Respiratory syncytial virus regulates human microRNAs by using mechanisms involving beta interferon and NF-κB,” mBio, vol. 3, no. 6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Zhang, M. Daucher, D. Armistead, R. Russell, and S. Kottilil, “MicroRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon-α,” PLoS ONE, vol. 8, no. 2, Article ID e55733, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Bruni, C. Marcantonio, A. Pulsoni et al., “microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus,” BMC Infectious Diseases, vol. 14, supplement 5, p. S6, 2014. View at Google Scholar
  34. S. Shwetha, K. Gouthamchandra, M. Chandra, B. Ravishankar, M. N. Khaja, and S. Das, “Circulating miRNA profile in HCV infected serum: novel insight into pathogenesis,” Scientific Reports, vol. 3, article 1555, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. R. El-Diwany, L. N. Wasilewski, K. W. Witwer et al., “Acute hepatitis C virus infection induces consistent changes in circulating MicroRNAs that are associated with nonlytic hepatocyte release,” Journal of Virology, vol. 89, no. 18, pp. 9454–9464, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Hsueh, S.-M. Jung, S.-R. Shih et al., “Acute encephalomyelitis during an outbreak of enterovirus type 71 infection in Taiwan: report of an autopsy case with pathologic, immunofluorescence, and molecular studies,” Modern Pathology, vol. 13, no. 11, pp. 1200–1205, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. K. T. Wong, “Emerging and re-emerging epidemic encephalitis: a tale of two viruses,” Neuropathology and Applied Neurobiology, vol. 26, no. 4, pp. 313–318, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Caputo, L. Sinibaldi, A. Fiorentino et al., “Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allele-specific binding,” PLoS ONE, vol. 6, no. 12, Article ID e28656, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Absalon, D. M. Kochanek, V. Raghavan, and A. M. Krichevsky, “MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, Tau-phosphorylation, and apoptosis in postmitotic neurons,” Journal of Neuroscience, vol. 33, no. 37, pp. 14645–14659, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Jovicic, J. F. Zaldivar Jolissaint, R. Moser, M. D. F. Silva Santos, and R. Luthi-Carter, “MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington' disease-related mechanisms,” PLoS ONE, vol. 8, no. 1, Article ID e54222, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. B. R. Cullen, “Viruses and microRNAs,” Nature Genetics, vol. 38, supplement, pp. S25–S30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Barnes, M. Kunitomi, M. Vignuzzi, K. Saksela, and R. Andino, “Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines,” Cell Host and Microbe, vol. 4, no. 3, pp. 239–248, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. K. D. Conrad and M. Niepmann, “The role of microRNAs in hepatitis C virus RNA replication,” Archives of Virology, vol. 159, no. 5, pp. 849–862, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. A. V. Kofman, C. Letson, E. Dupart et al., “The p53-microRNA-34a axis regulates cellular entry receptors for tumor-associated human herpes viruses,” Medical Hypotheses, vol. 81, no. 1, pp. 62–67, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Xun, C. F. Ma, Q. L. Du, Y. H. Ji, and J. R. Xu, “Differential expression of miRNAs in enterovirus 71-infected cells,” Virology Journal, vol. 12, article 56, 2015. View at Publisher · View at Google Scholar
  46. Q. Wang, X. Chen, J. Feng et al., “Soluble interleukin-6 receptor-mediated innate immune response to DNA and RNA viruses,” Journal of Virology, vol. 87, no. 20, pp. 11244–11254, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Michlmayr, C. S. McKimmie, M. Pingen et al., “Defining the chemokine basis for leukocyte recruitment during viral encephalitis,” Journal of Virology, vol. 88, no. 17, pp. 9553–9567, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Yang, X. Zhao, D. Sun et al., “Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A,” Cellular and Molecular Immunology, vol. 13, no. 1, pp. 94–102, 2016. View at Publisher · View at Google Scholar · View at Scopus
  49. S. M. Y. Lee, K.-H. Kok, M. Jaume et al., “Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 10, pp. 3793–3798, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Angelova, K. Zwezdaryk, M. Ferris, B. Shan, C. A. Morris, and D. E. Sullivan, “Human cytomegalovirus infection dysregulates the canonical Wnt/β-catenin signaling pathway,” PLoS Pathogens, vol. 8, no. 10, Article ID e1002959, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. M. B. Reeves, A. Breidenstein, and T. Compton, “Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 2, pp. 588–593, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Shirasaki, M. Honda, T. Shimakami et al., “Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway,” Hepatology, vol. 60, no. 5, pp. 1519–1530, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Öhman, S. Söderholm, M. Paidikondala, N. Lietzén, S. Matikainen, and T. A. Nyman, “Phosphoproteome characterization reveals that Sendai virus infection activates mTOR signaling in human epithelial cells,” Proteomics, vol. 15, no. 12, pp. 2087–2097, 2015. View at Publisher · View at Google Scholar · View at Scopus